The global Pharmaceutical Grade Phycocyanin market was valued at 31.33 Million USD in 2020 and will grow with a CAGR of 5.36% from 2020 to 2027, based on our Researcher newly published report.The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches.
Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).Phycocyanin is a pigment-protein complex from the light-harvesting phycobiliprotein family, along with allophycocyanin and phycoerythrin.
All phycobiliproteins are water-soluble, so they cannot exist within the membrane like carotenoids can.
Instead, phycobiliproteins aggregate to form clusters that adhere to the membrane called phycobilisomes.
Phycocyanin is a characteristic light blue color, absorbing orange and red light, particularly near 620 nm (depending on which specific type it is), and emits fluorescence at about 650 nm (also depending on which type it is).
Allophycocyanin absorbs and emits at longer wavelengths than phycocyanin C or phycocyanin R. Phycocyanins are found in Cyanobacteria (also called blue-green algae)Because the market competition of Pharmaceutical Grade Phycocyanin is not fierce globally, manufacturer can obtain considerable profit from the manufacturing and marketing of Pharmaceutical Grade Phycocyanin and that is the reason that we believe there will also be enterprises enter this market.